prof. dr. ir. An Hendrix
- Work address
-
C. Heymanslaan 10, ingang 97 - verdieping 2
9000 Gent - An.Hendrix@UGent.be
- ORCID iD
-
0000-0002-1883-8309
Show
Sort by
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
Assessing human embryo implantation competence through analysis of extracellular vesicles and their contents
-
- Journal Article
- A2
- open access
Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles
-
- Journal Article
- A1
- open access
Removal of platelets from blood plasma to improve the quality of extracellular vesicle research
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
- Journal Article
- A1
- open access
Hatching is modulated by microRNA-378a-3p derived from extracellular vesicles secreted by blastocysts
-
Metastasized orthotopic patient-derived xenografts as preclinical model to guide therapeutic decision making in soft tissue sarcoma patients
(2022) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. In European Journal of Surgical Oncology 48(2). p.e164-e165 -
- Journal Article
- A1
- open access
Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial
-
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
-
- Journal Article
- A1
- open access
MISpheroID : a knowledgebase and transparency tool for minimum information in spheroid identity